Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International Journal of Oncology

• Publication date

  2013-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijo.2013.1978PMID 23754252
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of oxaliplatin-induced neuropathy: a patient perspective

  2012cited by this paper
• Oxaliplatin responses in colorectal cancer cells are modulated by CHK2 kinase inhibitors

  2010cited by this paper
• Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells.

  2010cited by this paper
• Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice

  2010cited by this paper
• Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro

  2009cited by this paper
• Combination therapy of S-1 with selective cyclooxygenase-2 inhibitor for liver metastasis of colorectal carcinoma.

  2008cited by this paper
• p53 dependent and independent sensitivity to oxaliplatin of colon cancer cells.

  2007cited by this paper
• Selective Inhibition of Fatty Acid Synthase for Lung Cancer Treatment

  2007cited by this paper
• Adjuvant Treatment of Colon Cancer: Past, Present and Future

  2007cited by this paper
• Growth arrest induced by C75, A fatty acid synthase inhibitor, Was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma

  2006cited by this paper
• Cancer metastasis: building a framework.

  2006cited by this paper
• Fatty acid synthase and cancer: new application of an old pathway.

  2006cited by this paper
• Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells

  2005influential reference
• Development of cell cycle active drugs for the treatment of gastrointestinal cancers: a new approach to cancer therapy.

  2005cited by this paper
• Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer.

  2004cited by this paper
• Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer.

  2003cited by this paper
• Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma

  2002cited by this paper
• Regulation of the G2/M transition by p53

  2001cited by this paper
• p38 Map Kinase Mediates Bax Translocation in Nitric Oxide–Induced Apoptosis in Neurons

  2000cited by this paper
• p53-dependent cell cycle control: response to genotoxic stress.

  1998cited by this paper
• DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

  1997cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases

  1995cited by this paper
• Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*)

  1995cited by this paper
• A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

  1994cited by this paper
• Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27.

  1994cited by this paper
• A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins.

  1994cited by this paper
• A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.

  1994cited by this paper

• Metabolic reprogramming orchestrates an immunosuppressive microenvironment in anaplastic thyroid cancer: mechanisms and clinical perspectives.

  2026cites this paper
• Targeting fatty acid synthase for cancer drug discovery: Retrospective analyses and outlook.

  2025cites this paper
• Research progress and therapeutic strategies in hepatocellular carcinoma metabolic reprogramming.

  2025cites this paper
• Lipid metabolic reprogramming in colorectal cancer: mechanisms and therapeutic strategies

  2025cites this paper
• Fatty acid synthase inhibitor cerulenin attenuates glioblastoma progression by reducing EMT and stemness phenotypes, inducing oxidative and ER stress response, and targeting PI3K/AKT/NF-κB axis

  2025cites this paper
• Simultaneous Activation of Beta‐Oxidation and De Novo Lipogenesis in MASLD‐HCC: A New Paradigm

  2025cites this paper
• Histone Acyl Code in Precision Oncology: Mechanistic Insights from Dietary and Metabolic Factors

  2024cites this paper
• Oleate Epoxides Derived from Palm Oil as New Anticancer Agents: Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies Against FASN Protein

  2024cites this paper
• FAS Inhibited Proteomics and Phosphoproteomics Profiling of Colorectal Cancer Spheroids Shows Activation of Ferroptotic Death Mechanism.

  2024cites this paper
• Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy

  2024cites this paper
• Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways

  2024cites this paper
• STAT3 activation of SCAP-SREBP-1 signaling upregulates fatty acid synthesis to promote tumor growth

  2024cites this paper
• Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy

  2024cites this paper
• Metabolic reprogramming in cancer: Mechanisms and therapeutics

  2023cites this paper
• Role of EGFR and FASN in breast cancer progression

  2023cites this paper
• Protein Folding Stability Profiling of Colorectal Cancer Chemoresistance Identifies Functionally Relevant Biomarkers.

  2023cites this paper
• Targeting autophagy and lipid metabolism in cancer stem cells.

  2023cites this paper
• Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness

  2023cites this paper
• Metabolomics in oncology

  2023cites this paper
• Comparative Study of Autophagy in Oxaliplatin-Sensitive and Resistant SNU-C5 Colon Cancer Cells

  2022cites this paper
• Overview of Cancer Metabolism and Signaling Transduction

  2022cites this paper
• Comprehensive Analysis of FASN in Tumor Immune Infiltration and Prognostic Value for Immunotherapy and Promoter DNA Methylation

  2022cites this paper
• Single‐Atom Nanozyme with Asymmetric Electron Distribution for Tumor Catalytic Therapy by Disrupting Tumor Redox and Energy Metabolism Homeostasis

  2022cites this paper
• Lipid metabolism reprogramming in colorectal cancer

  2022influential citation
• Rerouting the drug response: Overcoming metabolic adaptation in KRAS-mutant cancers

  2022cites this paper
• Colon cancer and colorectal cancer: Prevention and treatment by potential natural products.

  2022cites this paper
• Metabolic pathways regulating colorectal cancer: a potential therapeutic approach.

  2022cites this paper
• Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells

  2022cites this paper
• Targeting Energy Metabolism in Cancer Treatment

  2022cites this paper
• Fatty acid synthesis and prostate cancer

  2021cites this paper
• Metabolic Strategies for Inhibiting Cancer Development.

  2021cites this paper
• Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation

  2021cites this paper
• Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy

  2021cites this paper
• The Potential Role of Changes in the Glucose and Lipid Metabolic Pathways in Gastrointestinal Cancer Progression: Strategy in Cancer Therapy

  2021cites this paper
• Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development

  2021cites this paper
• Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy

  2021cites this paper
• How cancer cells remodel lipid metabolism: strategies targeting transcription factors

  2021cites this paper
• The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer

  2021cites this paper
• Colorectal cancer stem cells: a review of targeted drug delivery by gold nanoparticles

  2020cites this paper
• Arachidonic acid induces ER stress and apoptosis in HT-29 human colon cancer cells

  2020cites this paper
• Inhibitors of Fatty Acid Synthesis and Oxidation as Potential Anticancer Agents in Colorectal Cancer Treatment

  2020cites this paper
• Metabolic Targeting of Cancer Stem Cells

  2020cites this paper
• Efficacy and mechanism of combination of oxaliplatin with PKM2 knockdown in colorectal cancer

  2020cites this paper
• Fatty Acid Synthase: An Emerging Target in Cancer

  2020cites this paper
• Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment

  2020cites this paper
• The MYC Oncogene Coope rates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth Graphical

  2019cites this paper
• The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth.

  2019cites this paper
• Natural products for treating colorectal cancer: A mechanistic review.

  2019cites this paper
• Emerging role of lipid metabolism alterations in Cancer stem cells

  2018cites this paper
• p53 and metabolism: from mechanism to therapeutics

  2018cites this paper
• Aloperine executes antitumor effects through the induction of apoptosis and cell cycle arrest in prostate cancer in vitro and in vivo

  2018cites this paper
• Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells

  2018cites this paper
• Small-Molecule Modulation of Lipid-Dependent Cellular Processes against Cancer: Fats on the Gunpoint

  2018cites this paper
• Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis

  2017cites this paper
• Metabolism and neural differentiation in childhood neuroblastoma

  2017cites this paper
• An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis.

  2017cites this paper
• MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression

  2017cites this paper
• β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1

  2016cites this paper
• Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer.

  2016cites this paper
• Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway

  2016cites this paper
• New Chemotherapeutic Agents: Monoterpenes and Fatty Acid Synthase Inhibitors

  2016cites this paper
• Targeting lipid metabolism for the treatment of anaplastic thyroid carcinoma

  2016cites this paper
• Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer

  2015cites this paper
• Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway

  2015cites this paper
• A Chinese herbal Formula, Chang-Wei-Qin, Synergistically Enhances Antitumor Effect of Oxaliplatin

  2015cites this paper
• Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibody Treatments

  2014cites this paper
• Targeting cytosolic phospholipase A2 α in colorectal cancer cells inhibits constitutively activated protein kinase B (AKT) and cell proliferation

  2014cites this paper
• Loss of PTEN stabilizes the lipid modifying enzyme cytosolic phospholipase A2α via AKT in prostate cancer cells

  2014cites this paper
• Triptolide Synergistically Enhances Antitumor Activity of Oxaliplatin in Colon Carcinoma In Vitro and In Vivo

  2014cites this paper
• Fatty Acid Synthase Inhibitor Cerulenin Suppresses Colorectal Cancer in Combination with Oxaliplatin

  2014influential citation
• Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibodies Perspective

  2014cites this paper
• Untargeted metabolomic study of lung cancer patients after surgery with curative intent: possible metabolites of good prognosis, intervention failure and recurrence

  year unknowncites this paper
• An essential role for the tumor suppressor Merlin in regulating An essential role for the tumor suppressor Merlin in regulating fatty acid synthesis. fatty acid synthesis.

  year unknowncites this paper